What Makes Insmed Incorporated (INSM) an Investment Bet?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” first quarter 2025 investor letter.
Insmed Inc (INSM)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Darwin Global Management Abhishek Trehan | 15,397,975 | $1,200,888,070 | +19% | 82.08% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 5,380,626 | $410,487,958 | +8% | 4.54% |
| 3. | Adage Capital Management Phill Gross And Robert Atchinson | 3,446,944 | $262,967,358 | +110% | 0.49% |
| 4. | 74,505,000 | $176,744,868 | +5% | 0.16% | |
| 5. | Holocene Advisors Brandon Haley | 2,026,422 | $154,595,734 | +195% | 0.45% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $66.35 | 1,130 | $74,975.50 | 3,025 | 2025-05-21 | Filing | |
| $66.87 | 1,895 | $126,718.65 | 1,895 | 2025-05-20 | Filing | |
| $19.29 | 10,000 | $192,900.00 | 10,000 | 2023-05-15 | Filing | |
| $19.29 | 10,000 | $192,900.00 | 298,615 | 2023-05-15 | Filing | |
| $17.70 | 10,000 | $177,000.00 | 15,900 | 2022-11-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $96.19 | 22,181 | $2,133,590.39 | 84,017 | 2025-07-07 | Filing | |
| $95.66 | 35,583 | $3,403,869.78 | 106,198 | 2025-07-07 | Filing | |
| $99.61 | 815 | $81,182.15 | 233,924 | 2025-07-01 | Filing | |
| $98.83 | 2,349 | $232,151.67 | 234,739 | 2025-07-01 | Filing | |
| $97.73 | 3,666 | $358,278.18 | 237,088 | 2025-07-01 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 73,404 | $7,387,379 | 0.01% | |
| 2. | 5,416 | $545,066 | 0.02% | |
| 3. | 4,487 | $451,572 | 0.03% | |
| 4. | 4,446 | $434,859 | 0% | |
| 5. | 2,041 | $205,406 | 0.51% |
News See All
Mizuho Reiterates Outperform Rating on Insmed (INSM), Boosts PT to $110
Insmed Inc. (NASDAQ:INSM) is one of the 10 best growth stocks to buy according to billionaires.
10 Best Growth Stocks to Buy According to Billionaires
Growth stocks are companies that are expected to report above-average earnings and revenue growth.
Wells Fargo Lifts Price Target on Insmed Incorporated (INSM) to $119 From $107
Insmed Incorporated (NASDAQ:INSM) is one of the 10 Hot Large Cap Stocks to Buy Now.
Goldman Sachs Hikes Insmed (INSM) Price Target to $112 Affirms Buy Rating
Insmed Incorporated (NASDAQ:INSM) is one of the 12 best healthcare stocks to buy now.
10 Hot Large Cap Stocks to Buy Now
On June 13, Tom McClellan, editor of The McClellan Market Report, appeared on CNBC's 'The Exchange' to talk about how the current geopolitical climate is expected to affect the stock market.
12 Best Healthcare Stocks to Buy Now
Healthcare companies in the US are facing policy headwinds under President Donald Trump's Administration.
Insmed Incorporated (INSM) Soars on Positive PAH Therapy Trial Results
Insmed Incorporated (NASDAQ:INSM) is among the 10 Best Growth Stocks Under $100 to Buy Now.
Insmed (INSM) Soars After Raising $650 million
We recently published a list of These 10 Stocks Are Flying High. In this article, we are going to take a look at where Insmed Inc.
Insmed Inc (INSM) Soars 30% on Impressive Study
We recently published a list of Investors Are Gobbling Up Shares of These 10 Firms.
Billionaire Hedge Funds
